Hikma receives FDA approval and launches the generic version of Victoza, Liraglutide, in the US
August 2023: Lawsuits Begin To Be Filed By People Harmed by Ozempic The first lawsuit is filed against the makers of Ozempic and its sister drug Wegovy alleges a failure to adequately warn consumers about the potential risk of harm associated with using the drugs
(PubMed) Traber MG, Leonard SW, Ebenuwa I, et al
How Klinics Comprehensive Approach Facilitates Weight Loss Klinics metabolic health program offers personalized tirzepatide weight loss plans tailored to your unique health needs
Candidates typically include adults with a Body Mass Index (BMI) of 30 or higher, classified as obese, or those with a BMI of 27 or higher who also face weight-related health challenges such as hypertension, type 2 diabetes, or dyslipidemia